Signal, not noise: learning to measure emphysema beyond the −950 HU threshold - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Beyond the −950 HU Threshold: Advancing Emphysema Measurement Techniques

  • By

  • Hongseok Ko

  • Jiyoung Song

  • Taehee Lee

  • September 11, 2026

Share

Clinical Scorecard: Beyond the −950 HU Threshold: Advancing Emphysema Measurement Techniques

At a Glance

Category

Detail

Condition

Emphysema

Key Mechanisms

CT imaging for quantifying lung parenchyma destruction.

Target Population

Patients with chronic obstructive pulmonary disease (COPD).

Care Setting

Clinical imaging and diagnostic settings.

Key Highlights

  • LAA-950 threshold is the current standard for measuring emphysema but has limitations.

  • Deep-learning-based segmentation shows improved reproducibility over traditional methods.

  • Photon-counting CT (PCCT) may enhance measurement accuracy with sharper kernels.

  • Longitudinal validation is needed to assess AI-derived emphysema measurements.

  • Clinical concordance with visual scores improved significantly with new methods.

Guideline-Based Recommendations

Diagnosis

  • Use CT imaging to quantify emphysema in COPD patients.

Management

  • Implement AI imaging techniques to assess emphysema extent and distribution.

Monitoring & Follow-up

  • Regularly evaluate emphysema progression using standardized imaging protocols.

Risks

  • Measurement variability due to scanner differences and imaging conditions.

Patient & Prescribing Data

Individuals diagnosed with COPD exhibiting emphysematous changes.

AI-derived measurements may provide more reliable assessments of disease progression.

Clinical Best Practices

  • Adopt deep learning models for emphysema quantification.

  • Ensure consistent imaging protocols across different scanners.

  • Utilize synthetic data for training AI models to improve accuracy.

Related Resources & Content

  • Losartan Effects on Emphysema Progression trial

  • Quantitative Imaging Biomarkers Alliance (QIBA) CT Lung Densitometry Profile

  • Vegas Sánchez-Ferrero et al. study

  • 2026 GOLD report

  • Sotoudeh-Paima et al. study

Original Source(s)

Related Content